Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Biomol Struct Dyn ; 42(6): 3051-3080, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-37203996

RESUMEN

Citrus sinensis (L.) Osbeck (Rutaceae), commonly known as the sweet orange, is a popular and widely consumed fruit with several medicinal properties. The present study aimed to perform the in silico screening of 18 flavonoids and eight volatile components from the peel of C. sinensis against apoptotic and inflammatory proteins, metalloprotease, and tumor suppressor markers. Flavonoids obtained higher probabilities than volatile components against selected anti-cancer drug targets. Hence, the data from the binding energies against the essential apoptotic and cell proliferation proteins substantiate that they may be promising compounds in developing effective candidates to block cell growth, proliferation, and induced cell death by activating the apoptotic pathway. Further, the binding stability of the selected targets and the corresponding molecules were analyzed by 100 ns molecular dynamics (MD) simulations. Chlorogenic acid has the most binding affinity against the important anti-cancer targets iNOS, MMP-9, and p53. The congruent binding mode to different drug targets focused on cancer shown by chlorogenic acid suggests that it may be a compound with significant therapeutic potential. Moreover, the binding energy predictions indicated that the compound had stable electrostatic and van der Waal energies. Thus, our data reinforce the medicinal importance of flavonoids from C. sinensis and expand the need for more studies, seeking to optimize results and amplify the impacts of further in vitro and in vivo studies. Communicated by Ramaswamy H. Sarma.


Asunto(s)
Citrus sinensis , Flavonoides , Flavonoides/farmacología , Flavonoides/química , Citrus sinensis/química , Simulación del Acoplamiento Molecular , Ácido Clorogénico , Antioxidantes/química , Simulación de Dinámica Molecular
2.
Chem Biol Drug Des ; 84(1): 116-22, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24460654

RESUMEN

Aspergillus flavus is a commonly found fungal pathogen which produces structurally related and highly toxic secondary metabolites, aflatoxins. It has been proposed that α-amylase inhibitors may limit the ability of the fungus to produce aflatoxins. Hence, this enzyme is a potent target for the development of antifungal agents. In this study, it was found that Spatholobus parviflorus seed lectin (SPL) can inhibit the growth of A. flavus with a MIC value of 1.5 mg/mL. The enzyme kinetics, molecular modeling and isothermal titration calorimetric studies suggest that SPL can inhibit α-amylase with Ki value of 0.0042 mm. Hence, it is suggested that the antifungal activity of SPL might be partly due to its ability to inhibit the enzyme α-amylase.


Asunto(s)
Antifúngicos/farmacología , Aspergillus flavus/enzimología , Fabaceae/química , Lectinas de Plantas/farmacología , alfa-Amilasas/antagonistas & inhibidores , Antifúngicos/química , Antifúngicos/aislamiento & purificación , Aspergilosis/tratamiento farmacológico , Aspergillus flavus/efectos de los fármacos , Humanos , Cinética , Simulación del Acoplamiento Molecular , Lectinas de Plantas/química , Lectinas de Plantas/aislamiento & purificación , Termodinámica , alfa-Amilasas/química , alfa-Amilasas/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA